Home
Conditions
Hemorrhagic Disorders

Clinical trial condition

Hemorrhagic Disorders

Explore clinical trials studying Hemorrhagic Disorders. Study availability and eligibility vary by location and protocol.

4,583 public trials 830 recruiting studies

Refine in advanced search Browse all conditions

Hemorrhagic Disorders trial results

Recruiting

The CACHE Study: Coronary Artery Care in HaEmophilia

NCT06706206

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Cardiovascular Diseases, +8 more
Locations: Oxford Haemophilia and Thrombosis Centre, Oxford University Hospitals NHS Foundation Trust Oxford, Oxfordshire, United Kingdom

View Trial Details

Recruiting

Phase 3 Study of Fibrinogen Concentrate (CSL511) in Subjects With Pseudomyxoma Peritonei Undergoing Cytoreductive Surgery

NCT06617897

Conditions: Acquired Fibrinogen Deficiency, Adenocarcinoma, Adenocarcinoma, Mucinous, +15 more
Locations: Basingstoke and North Hampshire Hospital Basingstoke, United Kingdom

View Trial Details

Recruiting

Efficacy of Nintedanib for Treatment of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) Patients

NCT04976036

Conditions: Cardiovascular Abnormalities, Cardiovascular Diseases, Congenital Abnormalities, +18 more
Locations: Lyon University Hospital, Dpt of genetics Bron, France

Clermont-Ferrand university hospital Clermont-Ferrand, France

Angiology Department, Lausanne University Hospital Lausanne, Canton of Vaud, Switzerland

View Trial Details

Recruiting

An Optimal Dose Finding Study of N-Acetylcysteine in Patients With Myeloproliferative Neoplasms

NCT05123365

Conditions: Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +16 more
Locations: University of California, Irvine Irvine, California, United States

Chao Family Comprehensive Cancer Center, University of California, Irvine Orange, California, United States

View Trial Details

Recruiting

Interest of CALR Allele Burden in Diagnosis and Follow-up of Patients With CALR Mutated Myeloproliferative Syndromes (CALRSUIVI)

NCT04942080

Conditions: Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +11 more
Locations: CHU Angers Angers, France

Chu Bordeaux Bordeaux, France

Chu Brest Brest, France

Ch Cholet Cholet, France

View Trial Details

Recruiting

Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma

NCT06375044

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations: Mayo Clinic Arizona Phoenix, Arizona, United States

Mayo Clinic Florida Jacksonville, Florida, United States

Dana Farber Cancer institution Boston, Massachusetts, United States

Mayo Clinic Rochester Rochester, Minnesota, United States

View Trial Details

Recruiting

A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma

NCT05730036

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: University of California Los Angeles (UCLA) Los Angeles, California, United States

University of Florida Division of Sponsored Programs Gainesville, Florida, United States

University of Kentucky, Markey Cancer Center Clinical Research Organization Lexington, Kentucky, United States

Norton Cancer Institute Louisville, Kentucky, United States

View all 159 locations

View Trial Details

Recruiting

Minimal Residual Disease Guided Maintenance Therapy With Belantamab Mafodotin and Lenalidomide After Autologous Hematopoietic Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma

NCT05091372

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Observational Study Evaluating the Efficacy and Safety of Zanubrutinib in Participants With Waldenström Macroglobulinemia

NCT05640102

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Clearview Cancer Institute Huntsville, Alabama, United States

South Alabama Medical Science Foundation Mitchell Cancer Institute Mobile, Alabama, United States

City of Hope National Medical Center Duarte, California, United States

Los Angeles Cancer Network (Lacn) Glendale, California, United States

View Trial Details

Recruiting

Investigating the Pathogenic Role of N-glycosylation in AL Amyloidosis: Molecular Bases, Diagnosis, and Treatment

NCT07448779

Conditions: AL Amyloidosis, Amyloidosis, Blood Protein Disorders, +20 more
Locations: Fondazione IRCCS Policlinico San Matteo di Pavia Pavia, PV, Italy

View Trial Details

Hemorrhagic Disorders

Hemorrhagic Disorders trial results

Related conditions